Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
Retractable Technologies, Inc. (RVP) declares dividends for its Series II Class B and Series III Class B Convertible Preferred Stock, totaling $39,050.00 and $18,561.25 respectively, covering the period from January 1, 2024, to March 31, 2024. The dividends will be paid on April 22, 2024, to shareholders of record as of April 10, 2024. Retractable manufactures safety medical products like VanishPoint® and Patient Safe® to prevent needlestick injuries and bloodstream infections.
LITTLE ELM, Texas–(BUSINESS WIRE)– Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2024 through March 31, 2024. The dividends will be paid on April 22, 2024 to shareholders of record as of the close of business on April 10, 2024.
Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint® needle also can be used to aspirate fluids and for blood collection. Retractable’s products are distributed by various specialty and general line distributors.
For more information on Retractable, visit its website at www.retractable.com.
Forward-looking statements in this press release are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable’s current views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate. However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from such statements.
Factors that could cause or contribute to such differences include, but are not limited to: supply chain disruptions, Retractable’s ability to scale up production volumes in response to an increase in demand, potential tariffs, Retractable’s ability to maintain liquidity; Retractable’s maintenance of patent protection; Retractable’s ability to maintain favorable third party manufacturing and supplier arrangements and relationships; foreign trade risk; Retractable’s ability to access the market; production costs; the impact of larger market players in providing devices to the safety market; and other risks and uncertainties that are detailed from time to time in Retractable’s periodic reports filed with the U.S. Securities and Exchange Commission.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240329185839/en/
Retractable Technologies, Inc.
John W. Fort III, 888-806-2626 or 972-294-1010
Vice President, Chief Financial Officer, and Chief Accounting Officer
Source: Retractable Technologies, Inc.
Retractable declared dividends of $39,050.00 and $18,561.25 for its Series II and Series III Class B Convertible Preferred Stock respectively.
The dividends will be paid on April 22, 2024, to shareholders of record as of April 10, 2024.
Retractable manufactures VanishPoint® syringes, blood collection, and IV catheter products, Patient Safe® syringes, and EasyPoint® needles designed to prevent needlestick injuries and bloodstream infections.
The VanishPoint® syringe retracts the needle directly from the patient, effectively reducing exposure to contaminated needles.
For more information on Retractable, visit its website at www.retractable.com.
NYSE:RVP
RVP Rankings
#4817 Ranked by Stock Gains
RVP Latest News
RVP Stock Data
Surgical and Medical Instrument Manufacturing
Manufacturing
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
About RVP
our vision: through innovation, education, and the development of safe and reliable medical devices, we strive to be a catalyst in reducing the worldwide spread of infectious disease. our mission: to build a model corporation for employees, customers, community, and shareholders based on performance, pride, and profit; to set a standard for excellence, effectiveness, and integrity in selling and delivering our products; and to establish mutually beneficial relationships with other companies who share our overall vision.
